Locations
San Francisco, CA, USA · United States · North America
industry
Software · Health · Education · Biotechnology · DeepTech
Size
51-200 employees
Stage
Other
founded in
2012
Atomwise Inc. is a deep learning AI technology for structure-based small molecule drug discovery. Atomwise performs hundreds of projects per year in partnership with some of the world’s largest pharmaceutical and agrochemical companies, as well as more than 200 universities and hospitals in 40 countries. Its speed and accuracy make it the most advanced technology for small molecule binding affinity prediction. AtomNet, its AI platform built for drug discovery contains more than 16 billion molecules for virtual screening.
Something looks off?